MGCLF - MGC Pharmaceuticals Ltd reports FY results February, 28 2019 05:00 AM MGC Pharmaceuticals Ltd MGC Pharmaceuticals Ltd (OTCPK:MGCLF): FY GAAP EPS of $0.05. Revenue of $0.29M (+866.7% Y/Y) Press Release More news on: MGC Pharmaceuticals Ltd, Earnings news and commentary, Healthcare stocks news, ,